0001209191-18-054429.txt : 20181005 0001209191-18-054429.hdr.sgml : 20181005 20181005172844 ACCESSION NUMBER: 0001209191-18-054429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181003 FILED AS OF DATE: 20181005 DATE AS OF CHANGE: 20181005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bhatia Sangeeta N. CENTRAL INDEX KEY: 0001643921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 181111422 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-03 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001643921 Bhatia Sangeeta N. C/O VERTEX PHARMACEUTICALS INCORPORATED BOSTON MA 02210 1 0 0 0 Common Stock 2018-10-03 4 M 0 2118 125.71 A 6997 D Common Stock 2018-10-03 4 S 0 2118 192.13 D 4879 D Common Stock 2018-10-03 4 M 0 4700 126.68 A 9579 D Common Stock 2018-10-03 4 S 0 4700 192.13 D 4879 D Stock Option (Right to Buy) 125.71 2018-10-03 4 M 0 2118 0.00 D 2027-05-31 Common Stock 2118 3177 D Stock Option (Right to Buy) 126.68 2018-10-03 4 M 0 4700 0.00 D 2025-06-03 Common Stock 4700 14547 D Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 6/1/2017. The option vests in 16 quarterly installments from 6/4/2015. /s/ Stephen Migausky, Attorney-in-Fact 2018-10-05